Login / Signup

Evaluation of the safety of sodium-glucose co-transporter-2 inhibitors for treating patients with type 1 diabetes.

Weihao WangLina ZhangXiaobei PeiQi PanLixin Guo
Published in: Diabetes, obesity & metabolism (2020)
Despite showing some promise as a treatment approach, the application of SGLT-2 inhibitors for patients with T1D should be considered with caution.
Keyphrases
  • big data
  • machine learning
  • artificial intelligence
  • deep learning
  • replacement therapy